Victor Mazza, MD
Clinical Cardiac Electrophysiology · Denville, NJNPI 1841358066
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,733 of the $8,699 with a category attached, or 65.9%. 33 manufacturers reported payments, led by Abbott at 31.7% of the total. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in NJ, where the typical reported total is $15,131.
Across 160 payments — averaging $54.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$1K
- Medtronic$1K
- Vivaquant Inc, Dba Rhythm Express$1K
- Intra-sana Laboratories$428
- Boston Scientific$271
- plus $1K from 27 others
What the payments were for
- Consulting fees$1,25014%
- Speaking & faculty fees$7509%
- Travel & lodging$96611%
- Food & beverage$5,73366%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 28 | $2,754 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 26 | $1,292 |
| Medtronic(2 entities) | 19 | $1,292 |
| Vivaquant Inc, Dba Rhythm Express | 2 | $1,250 |
| Intra-sana Laboratories | 4 | $428 |
| Boston Scientific | 11 | $271 |
| Novo Nordisk | 3 | $242 |
| Novartis | 14 | $174 |
| Merck | 9 | $131 |
| Heartflow, Inc. | 5 | $101 |
| Baxter Healthcare | 2 | $88 |
| E.r. Squibb & Sons, L.L.C. | 5 | $78 |
| Biosense Webster, Inc. | 1 | $67 |
| Pfizer | 4 | $65 |
| GSK | 1 | $61 |
| Amgen | 3 | $51 |
| Philips North America LLC | 2 | $42 |
| Altathera Pharmaceuticals LLC | 3 | $38 |
| Boehringer Ingelheim | 2 | $35 |
| Vifor Pharma, Inc. | 2 | $26 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Cvrx, Inc. | 2 | $23 |
| Infobionic, Inc | 1 | $19 |
| Kestra Medical Technology Services, Inc. | 1 | $19 |
| Biotronik Inc. | 1 | $18 |
| Bayer | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Corcept Therapeutics | 1 | $14 |
| Lexicon Pharmaceuticals, Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Astellas Pharma US Inc | 1 | $12 |
| Althera Pharmaceuticals LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$1,309
- RHYTHM EXPRESS$1,250
- LifeVest$864
- Confirm Rx$447
- Reltone 200 Mg$414
- GLYCATE$414
- Reltone 400 Mg$414
- CLARIA MRI QUAD CRT-D SURESCAN$300
- Viva$221
- Claria MRI$144
- AZURE XT DR MRI SURESCAN$127
- Wegovy$125
- LOOP$121
- Reveal LINQ$113
- Quadra Assura CRT Defibrillator$109
How this compares
$8,699 in reported general payments places this provider in the 30th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
See all clinical cardiac electrophysiology providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 241 | $210,512 |
| EntrestoSacubitril/Valsartan | 83 | $78,431 |
| XareltoRivaroxaban | 29 | $30,962 |
| Metoprolol Succinate | 436 | $5,702 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 15 | $1,784 |
| Midodrine Hcl | 28 | $1,409 |
| Atorvastatin Calcium | 121 | $1,240 |
| Amiodarone Hcl | 47 | $1,223 |
| Losartan Potassium | 138 | $988 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 31 | $899 |
| Bisoprolol Fumarate | 30 | $863 |
| Amlodipine Besylate | 143 | $714 |
| Digoxin | 36 | $540 |
| Valsartan | 18 | $518 |
| Diltiazem Hcl | 18 | $486 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $65 | $210,512241 claims |
| NovartisEntresto | $174 | $78,43183 claims |
| Johnson & JohnsonXarelto | $15 | $30,96229 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
Other clinical cardiac electrophysiology in Denville
- Benjamin D SouzaCherry Hill$741K
- Suneet MittalParamus$722K
- George MarkHaddon Heights$312K
- Raffaele CorbisieroBrowns Mills$135K
- Emad AzizNewark$112K
- Marc RoelkeWest Orange$110K
- Arjun TheerthamParlin$102K
- Michael LinkGalloway$96K
- Grant SimonsEnglewood$93K
- Jonathan SteinbergRidgewood$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.